OTC Obesity - Ukraine

In 2009, OTC obesity sales decreased by 5% in current value terms. The only brand present is Xenical, which was not supported with TV advertising and posters in drugstores and pharmacies in 2009, whilst in 2008 it was. Due to the devaluation of the local currency, retail prices in 2009 increased by 36% compared to 2008. High unit prices and the economic downturn had a negative impact on the demand. The demand for Xenical is seasonal; the highest demand is over autumn, winter and spring,...

Euromonitor International's OTC Obesity Products in Ukraine report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

Product coverage:

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health industry;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.